Home

Krishna Vaddi, CEO: Prelude Therapeutics PRLD Buy · Filed 25/03/24

Trade details

Type
Insider buy
Amount
$3,953.68
Shares · price
5,416 sh · $0.73 a share
Held after
1,309,296 sh
Trade date
25/03/20
Filed
25/03/24
Days to filing
4 days

First buy since 2023

Insiders buying this week
2 insiders
Holding change
+0.4%

Prelude Therapeutics trades, last 26 weeks

What else happened in Prelude Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/18~25/04/19

Krishna Vaddi's recent trades

  • Krishna Vaddi

    BuyPrelude Therapeutics

    $465.8K

    Filed 25/03/27

  • Krishna Vaddi

    BuyPrelude Therapeutics

    $11K

    Filed 25/03/24

  • Krishna Vaddi

    BuyPrelude Therapeutics

    $22.5K

    Filed 25/03/18

  • Krishna Vaddi

    BuyPrelude Therapeutics

    $6,830

    Filed 25/03/18

  • Krishna Vaddi

    BuyPrelude Therapeutics

    $36K

    Filed 25/03/14

Krishna Vaddi, CEO — bought $3,954 of Prelude Therapeutics PRLD · 5,416 sh @ $0.73 | Whalegun